| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 27/04/2015 | 09:21 | Analyst Ratings Network | Roth Capital Initiates Coverage on Mast Therapeutics (ANX) | AMEX:ANX | Mast Therapeutics, Inc. |
| 16/06/2014 | 14:00 | PR Newswire (US) | Mast Therapeutics Initiates Sub-Study Within Phase 3 EPIC Trial | AMEX:ANX | Mast Therapeutics, Inc. |
| 14/04/2014 | 14:00 | PR Newswire (US) | Mast Therapeutics Announces New Data Supporting MST-188 In Sickle Cell Disease | AMEX:ANX | Mast Therapeutics, Inc. |
| 10/02/2014 | 14:00 | PR Newswire (US) | Mast Therapeutics Signs Definitive Agreement To Acquire Aires Pharmaceuticals, Inc. | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/09/2013 | 14:00 | PR Newswire (US) | Mast Therapeutics To Present At The Rodman & Renshaw 15th Annual Healthcare Conference On September 10 | AMEX:ANX | Mast Therapeutics, Inc. |
| 11/03/2013 | 13:00 | PR Newswire (US) | ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX" | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/03/2013 | 22:11 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:ANX | Mast Therapeutics, Inc. |
| 28/02/2013 | 23:15 | PR Newswire (US) | ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX" | AMEX:ANX | Mast Therapeutics, Inc. |
| 28/02/2013 | 22:01 | PR Newswire (US) | Adventrx To Develop ANX-188 For Complications Of Arterial Disease | AMEX:ANX | Mast Therapeutics, Inc. |
| 26/02/2013 | 14:00 | PR Newswire (US) | ADVENTRX Reviews Data Supporting Development Of ANX-188 In New Indications | AMEX:ANX | Mast Therapeutics, Inc. |
| 25/02/2013 | 14:00 | PR Newswire (US) | ADVENTRX To Present At The Cowen And Company 33rd Annual Health Care Conference On March 4 | AMEX:ANX | Mast Therapeutics, Inc. |
| 11/02/2013 | 14:00 | PR Newswire (US) | ADVENTRX Initiates Thorough QT/QTc Clinical Study Of ANX-188 | AMEX:ANX | Mast Therapeutics, Inc. |
| 05/02/2013 | 14:00 | PR Newswire (US) | ADVENTRX To Present At The 15th Annual BIO CEO & Investor Conference On February 12 | AMEX:ANX | Mast Therapeutics, Inc. |
| 30/01/2013 | 13:00 | PR Newswire (US) | ADVENTRX Initiates Pivotal Phase 3 Study of ANX-188 | AMEX:ANX | Mast Therapeutics, Inc. |
| 19/01/2013 | 00:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
| 10/01/2013 | 15:55 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | AMEX:ANX | Mast Therapeutics, Inc. |
| 10/01/2013 | 15:55 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/01/2013 | 14:00 | PR Newswire (US) | ADVENTRX Announces Appointment of Chief Financial Officer | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/01/2013 | 22:40 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/01/2013 | 12:07 | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/01/2013 | 14:00 | PR Newswire (US) | ADVENTRX To Present At The 6th Annual OneMedForum Emerging Company Finance Conference On January 8 | AMEX:ANX | Mast Therapeutics, Inc. |
| 19/12/2012 | 22:19 | Edgar (US Regulatory) | Other Filing (40-app/a) | AMEX:ANX | Mast Therapeutics, Inc. |
| 19/12/2012 | 14:00 | PR Newswire (US) | ADVENTRX To Initiate Phase 3 Study Of ANX-188 | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/12/2012 | 14:30 | PR Newswire (US) | ADVENTRX Announces Launch Of New Corporate Website | AMEX:ANX | Mast Therapeutics, Inc. |
| 05/11/2012 | 23:03 | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:ANX | Mast Therapeutics, Inc. |
| 05/11/2012 | 14:00 | PR Newswire (US) | ADVENTRX Reports Third Quarter 2012 Financial Results | AMEX:ANX | Mast Therapeutics, Inc. |
| 25/10/2012 | 22:05 | PR Newswire (US) | ADVENTRX Announces Details Of The Phase 3 Study Of ANX-188 | AMEX:ANX | Mast Therapeutics, Inc. |
| 23/10/2012 | 14:30 | PR Newswire (US) | ADVENTRX Announces Conference Call To Review Protocol For Phase 3 Clinical Study Of ANX-188 | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/10/2012 | 14:00 | PR Newswire (US) | ADVENTRX Engages Theradex Systems, Inc. to Manage Phase 3 Clinical Study of ANX-188 | AMEX:ANX | Mast Therapeutics, Inc. |
| 07/09/2012 | 18:58 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | AMEX:ANX | Mast Therapeutics, Inc. |
